Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02451865
Title Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Jonsson Comprehensive Cancer Center

lung non-small cell carcinoma


Binimetinib + Docetaxel

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST